Primary Site >> Colorectal Cancer

Gene >> CD74

Journal: Immunology. 1999 Oct;98(2):296-302.
Title: Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines.
Author: Ong, G L|Goldenberg, D M|Hansen, H J|Mattes, M J
PMID: 10540230
Journal: World J Gastroenterol. 2010 Jul 14;16(26):3258-66.
Title: CD74 is a survival receptor on colon epithelial cells.
Author: Maharshak, Nitsan|Cohen, Sivan|Lantner, Frida|Hart, Gili|Leng, Lin|Bucala, Richard|Shachar, Idit
PMID: 20614481
Journal: Int J Clin Exp Pathol. 2010 Nov 23;4(1):1-12.
Title: Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.
Author: Gold, David V|Stein, Rhona|Burton, Jack|Goldenberg, David M
PMID: 21228923
Journal: PLoS One. 2014 Jun 2;9(6):e98656.
Title: Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers.
Author: Morris, Katherine T|Nofchissey, Robert A|Pinchuk, Irina V|Beswick, Ellen J
PMID: 24887129
Journal: Oncotarget. 2016 Jul 19;7(29):45538-45546.
Title: Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.
Author: Xia, Pu|Xu, Xiao-Yan
PMID: 27323782
Journal: Int J Oncol. 2016 Nov;49(5):2163-2172.
Title: GSK-3beta-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
Author: Park, Ga Bin|Chung, Yoon Hee|Gong, Ji Hee|Jin, Dong-Hoon|Kim, Daejin
PMID: 27599658
Journal: J Exp Clin Cancer Res. 2017 Jan 23;36(1):16.
Title: MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.
Author: Bozzi, Fabio|Mogavero, Angela|Varinelli, Luca|Belfiore, Antonino|Manenti, Giacomo|Caccia, Claudio|Volpi, Chiara C|Beznoussenko, Galina V|Milione, Massimo|Leoni, Valerio|Gloghini, Annunziata|Mironov, Alexandre A|Leo, Ermanno|Pilotti, Silvana|Pierotti, Marc
PMID: 28114961
Journal: Pharmacol Res. 2017 Jul;121:202-212.
Title: ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Author: Roskoski, Robert Jr
PMID: 28465216